VSee Health corrected its proposed reverse stock split cap to a maximum 80-for-1 from up to 250-for-1.
The revised limit remains subject to regulatory requirements and shareholder approval, aimed at supporting its Nasdaq listing.
The company terminated its previously announced standby equity purchase agreement, leaving no active equity facility expected to drive near-term dilution.
VSEE•
